Interpretation on the report of global cancer statistics 2022
10.3760/cma.j.cn112152-20240416-00152
- VernacularTitle:2022年全球恶性肿瘤统计报告解读
- Author:
Xi ZHANG
1
;
Lei YANG
;
Shuo LIU
;
Lili CAO
;
Ning WANG
;
Huichao LI
;
Jiafu JI
Author Information
1. 北京大学肿瘤医院暨北京市肿瘤防治研究所北京市肿瘤防治研究办公室 恶性肿瘤发病机制及转化研究教育部重点实验室，北京 100142
- Keywords:
Neoplasms;
Cancer registration;
Incidence;
Mortality;
Cancer burden;
GLOBOCAN 2022
- From:
Chinese Journal of Oncology
2024;46(7):710-721
- CountryChina
- Language:Chinese
-
Abstract:
In April 2024, the World Health Organization/International Agency for Research on Cancer (IARC) published the global cancer statistics 2022 in the CA: Cancer Journal for Clinicians. This report focuses on the incidence and mortality of 36 cancers in 185 countries or territories worldwide, analyzing the differences of gender, geographic region, and the Human Development Index (HDI) level. It is estimated that in the year 2022, there were 19.96 million new cancer cases and 9.74 million cancer deaths worldwide. Lung cancer (2 480 301, 12.4%) was the most frequently diagnosed cancer in 2022, followed by female breast cancer (2 295 686, 11.5%), colorectal cancer (1 926 118, 9.6%), prostate cancer (1 466 680, 7.3%), and gastric cancer (968 350, 4.9%). Lung cancer (1 817 172, 18.7%) was also the leading cause of cancer death, followed by colorectal cancer (903 859, 9.3%), liver cancer (757 948, 7.8%), female breast cancer (665 684, 6.9%), and gastric cancer (659 853, 6.8%). With demographics-based predictions indicating that the number of new cases of cancer will reach over 35 million by 2050. The Beijing Office for Cancer Prevention and Control team has collated this report and briefly interpreted it in combination with the current situation of cancer incidence and mortality in China.
